However, if cardiomyocyte-specific targeting and overexpression of TFEB in cardiomyocytes are needed, for example, to reverse cardiac hypertrophy associated with Pompe’s disease, it may be important to further increase tissue-specific delivery. Here, TFEB is linked to cardiac hypertrophy.